(MENAFN- GlobeNewsWire - Nasdaq) Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "7th Annual Real-World Evidence and Life Sciences Analytics Conference" conference has been added to ResearchAndMarkets.com's offering.
The 7th Annual Real-World Evidence and Life Science Analytics Conference is taking place in Boston on October 17-18th, 2024 - a premier gathering of thought leaders, industry experts, and innovators at the forefront of revolutionizing healthcare through data-driven insights. Set against the backdrop of advancements in real-world evidence, this conference promises an enriching experience for professionals in life sciences, healthcare, and analytics.
The 7th Annual Real-World Evidence and Life Science Analytics Conference is not just an event; it's an opportunity to be part of the conversation shaping the future of healthcare. Join us for an inspiring and collaborative experience as we explore ways to bridge insights to impact in the dynamic world of real-world evidence.
Key Highlights:
Gain insights into regulatory perspectives on data quality and standards, Integration of RWE into Clinical Trials Explore the strategic utilization of Real-World Evidence (RWE) to enhance market access. Regulatory Landscape for Medical Devices, Post-Market Surveillance and Safety Monitoring Uncover the expanded realm of RWE's influence on digital health, Patient-Centric Approaches in Device Research Examine the synergy between Real-World Data and Advanced Analytics, Economic impact evaluations using real-world evidence. Epidemiological Insights using Real World Evidence
Why Attend?
Latest insights and updates on trends Networking opportunities Professional Development Interdisciplinary Learning Insights into current regulatory perspectives Access to Thought Leaders Showcasing innovative technologies
Conference Agenda:
Day 1
Evidence Synergy: Bridging Outcomes, Access, and Analytics for Real-World Impact
Opening remarks by the Chairperson Integration of RWE into Clinical Trials Keynote Presentation - Strategies for incorporating real-world data into traditional clinical trial designs Health system adoption of evidence from clinical trials and real-world studies
Patient-Centered Outcomes Research
Using Patient-Generated Health Data for more Nuanced Clinical Outcomes for Medical Product Development Nancy Dreyer, Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill Measuring what you want to manage: new approaches to measure patient diversity in RWE Adrian Kielhorn, Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc
Health Economics and Market Access
Economic impact evaluations using real-world evidence Understanding the data leader's role in establishing the value of RWD Lou Brooks, Senior Vice President, Real-World Data and Analytics, Optum Life Sciences Eric Fontana, Vice President, Client Solutions, Real-World Data, Optum Life Science Demonstrating value and reimbursement strategies
AI and ML Applications in Life Sciences RWE
AI and ML in life sciences: Buzz words? or Reason for Optimism! Ravi Iyer, Sr. Director,Head Real World Evidence Strategy,GHEOR, Teva Pharmaceuticals Predictive analytics for patient recruitment, enrollment, and retention
Day 2
InnovateHealth: Precision Solutions in Evidence, Medicine, and Epidemiology
Welcome note Opening remarks by the Chairperson
Healthcare Innovation and Technology
Blockchain and other technologies for data integrity and transparency Impact of technological advancements on patient outcomes
Precision Medicine and Personalized Healthcare
Genomic data integration in patient outcomes research Tailoring treatments based on real-world evidence
Epidemiological Insights from Real-World Evidence
Large-scale epidemiological studies using real-world evidence Population-level insights for public health decision-making
Conference Speakers
Megan Sutton, Senior Medical Director, Clinical Development and Real-world Evidence, Lexeo Therapeutics Adrian Kielhorn, Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc Amit Kulkarni, Head of Health Economic Modeling and Decision Sciences, Otsuka Pharmaceutical Companies Nancy Dreyer, Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill Ravi Iyer, Sr. Director, Head Real World Evidence Strategy, GHEOR, Teva Pharmaceuticals Prasun Mishra, Co-Founder, Precision BioPharma Lou Brooks, Senior Vice President, Real-World Data and Analytics, Optum Life Sciences Eric Fontana, Vice President, Client Solutions, Real-World Data, Optum Life Sciences
For more information about this conference visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
MENAFN02072024004107003653ID1108397165
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.